Main objectives: Innovative approaches for the development of high-selectivity diagnostic, therapeutic and/or pre-emptive strategies in medical oncology. Study of the molecular alterations involved in the onset, progression and dispersal of
family and sporadic tumors, through experimental models in vitro, ex-vivo and in vivo. Use of “high throughput” approaches for the definition of tumor genomic and epigenomic panorama, proteomics and metabolics. 

The aim of the Ph.D. is to train professionals with interdisciplinary skills in oncological research, autonomy in planning, execution and interpretation of experiments, formulation of research projects and writing of scientific articles.